|
|
|
Volumn 33, Issue 3, 1996, Pages 319-328
|
|
A phase 3 clinical trial of123I-iomazenii, a new central-type benzodiazepine receptor imaging agent (part 3) - Report on clinical usefulness in epilepsy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE RECEPTOR;
IODINE 123;
IOMAZENIL;
ADULT;
AGED;
ARTICLE;
BRAIN BLOOD FLOW;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
ELECTROENCEPHALOGRAM;
EPILEPSY;
FOCAL EPILEPSY;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 3 CLINICAL TRIAL;
RECEPTOR BINDING;
ADULT;
BRAIN;
EPILEPSY;
FEMALE;
FLUMAZENIL;
HUMANS;
IODINE RADIOISOTOPES;
JAPAN;
MALE;
PREDICTIVE VALUE OF TESTS;
RECEPTORS, GABA-A;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
|
EID: 0029981388
PISSN: 00227854
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (4)
|
